Fumi Goshima
Nagoya, 4668550, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Genome-wide CRISPR screen for HSV-1 host factors reveals PAPSS1 contributes to heparan sulfate synthesis.
Journal: Communications biology
Published: September 20, 2021
Oncolytic activity of naturally attenuated herpes-simplex virus HF10 against an immunocompetent model of oral carcinoma.
Journal: Molecular therapy oncolytics
Published: May 19, 2020
Antitumor activity of cyclin-dependent kinase inhibitor alsterpaullone in Epstein-Barr virus-associated lymphoproliferative disorders.
Journal: Cancer science
Published: June 04, 2019
Oncolytic activity of HF10 in head and neck squamous cell carcinomas.
Journal: Cancer gene therapy
Published: April 09, 2019
Initial Characterization of the Epstein⁻Barr Virus BSRF1 Gene Product.
Journal: Viruses
Published: February 21, 2019
Publisher Correction: Defective Epstein-Barr virus in chronic active infection and haematological malignancy.
Journal: Nature microbiology
Published: February 02, 2019
The BOLF1 gene is necessary for effective Epstein-Barr viral infectivity.
Journal: Virology
Published: November 15, 2018
S-Like-Phase Cyclin-Dependent Kinases Stabilize the Epstein-Barr Virus BDLF4 Protein To Temporally Control Late Gene Transcription.
Journal: Journal of virology
Published: September 27, 2018
Oncolytic Virotherapy by HSV.
Journal: Advances in experimental medicine and biology
Published: June 14, 2018
Defective Epstein-Barr virus in chronic active infection and haematological malignancy.
Journal: Nature microbiology
Published: June 01, 2018
Characterization of a Suppressive Cis-acting Element in the Epstein-Barr Virus LMP1 Promoter.
Journal: Frontiers in microbiology
Published: August 09, 2017
Last Updated: 09/26/2026